These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17207174)

  • 21. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
    Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
    Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study.
    Yan AC; Honig PJ; Ming ME; Weber J; Shah KN
    Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
    Dawid M; Veensalu M; Grassberger M; Wolff K
    J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
    Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
    Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies.
    Paller AS; Lebwohl M; Fleischer AB; Antaya R; Langley RG; Kirsner RS; Blum RR; Rico MJ; Jaracz E; Crowe A; Linowski GJ;
    J Am Acad Dermatol; 2005 May; 52(5):810-22. PubMed ID: 15858471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
    Chu CY
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba.
    Fujita WH; McCormick CL; Parneix-Spake A
    Int J Dermatol; 2007 Jul; 46(7):700-5. PubMed ID: 17614797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
    Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T
    Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
    Cicek D; Kandi B; Bakar S; Turgut D
    J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of pimecrolimus cream 1% in the daily practice: results of a patient self-observation study in patients with atopic dermatitis.
    Luger TA; Gollnick H; Schwennesen T; Bextermöller R; Freytag S; Bräutigam M
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):908-14. PubMed ID: 17910673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
    Paul C; Cork M; Rossi AB; Papp KA; Barbier N; de Prost Y
    Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis.
    Kempers S; Boguniewicz M; Carter E; Jarratt M; Pariser D; Stewart D; Stiller M; Tschen E; Chon K; Wisseh S; Abrams B
    J Am Acad Dermatol; 2004 Oct; 51(4):515-25. PubMed ID: 15389185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.
    Siegfried E; Korman N; Molina C; Kianifard F; Abrams K
    J Dermatolog Treat; 2006; 17(3):143-50. PubMed ID: 16854753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
    Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
    Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCT.
    Bauer A; Lange N; Matterne U; Meurer M; Braeutigam M; Diepgen TL
    J Dtsch Dermatol Ges; 2012 Jun; 10(6):426-33. PubMed ID: 22112014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.